Advertisement
Screener

PFIZER INC (PFE) Acquisitions, Net of Cash Acquired

2.8 / 5 stars · 68/120 Roast Me

PFIZER INC Acquisitions, Net of Cash Acquired

PFIZER INC (PFE) reported Acquisitions, Net of Cash Acquired of $6.93 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-02-26

  • PFIZER INC payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • PFIZER INC payments to acquire businesses, net of cash acquired for the quarter ending 2024-09-29 was $0.00.
  • PFIZER INC payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $43.41B, a 158.79% increase year-over-year.
  • PFIZER INC payments to acquire businesses, net of cash acquired for the quarter ending 2023-10-01 was $0.00.
  • PFIZER INC payments to acquire businesses, net of cash acquired for fiscal 2025 was $6.93B.
  • PFIZER INC payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • PFIZER INC payments to acquire businesses, net of cash acquired for fiscal 2023 was $43.43B, a 88.85% increase from fiscal 2022.
  • PFIZER INC payments to acquire businesses, net of cash acquired for fiscal 2022 was $23.00B.
Period endPayments to Acquire Businesses, Net of Cash Acquired 3 monthPayments to Acquire Businesses, Net of Cash Acquired 6 monthPayments to Acquire Businesses, Net of Cash Acquired 9 monthPayments to Acquire Businesses, Net of Cash Acquired 12 month
2025-12-31$6.93B
10-K · filed 2026-02-26
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2024-09-29$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
$0.00
10-Q · filed 2024-11-04
2024-06-30$0.00
10-Q · filed 2024-08-05
2023-12-31$43.41B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$43.41B
derived: sum of 2 quarters · filed 2026-02-26
$43.43B
derived: sum of 3 quarters · filed 2026-02-26
$43.43B
10-K · filed 2026-02-26
2023-10-01$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
$25.00M
derived: sum of 2 quarters · filed 2024-11-04
$25.00M
10-Q · filed 2024-11-04
$16.80B
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02$25.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
$25.00M
10-Q · filed 2024-08-05
$16.80B
derived: sum of 3 quarters · filed 2025-02-27
$16.80B
derived: sum of 4 quarters · filed 2025-02-27
2023-04-02$0.00
10-Q · filed 2023-05-10
$16.77B
derived: sum of 2 quarters · filed 2025-02-27
$16.77B
derived: sum of 3 quarters · filed 2025-02-27
$16.77B
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$16.77B
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$16.77B
derived: sum of 2 quarters · filed 2025-02-27
$16.77B
derived: sum of 3 quarters · filed 2025-02-27
$23.00B
10-K · filed 2025-02-27
2022-10-02$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$0.00
derived: sum of 2 quarters · filed 2023-11-08
$6.22B
10-Q · filed 2023-11-08
$6.22B
derived: sum of 4 quarters · filed 2024-02-22
2022-07-03$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$6.22B
10-Q · filed 2023-08-09
$6.22B
derived: sum of 3 quarters · filed 2024-02-22
$6.22B
derived: sum of 4 quarters · filed 2024-02-22
2022-04-03$6.22B
10-Q · filed 2023-05-10
$6.22B
derived: sum of 2 quarters · filed 2024-02-22
$6.22B
derived: sum of 3 quarters · filed 2024-02-22
$6.22B
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$0.00
derived: sum of 2 quarters · filed 2024-02-22
$0.00
derived: sum of 3 quarters · filed 2024-02-22
$0.00
10-K · filed 2024-02-22
2021-10-03$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$0.00
10-Q · filed 2022-11-09
$0.00
derived: sum of 4 quarters · filed 2023-02-23
2021-07-04$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$0.00
10-Q · filed 2022-08-10
$0.00
derived: sum of 3 quarters · filed 2023-02-23
2021-04-04$0.00
10-Q · filed 2022-05-11
$0.00
derived: sum of 2 quarters · filed 2023-02-23
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$0.00
10-K · filed 2023-02-23
2020-09-27$0.00
10-Q · filed 2020-11-05
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$10.86B
10-K · filed 2022-02-24
2019-09-29$10.86B
10-Q · filed 2020-11-05
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$0.00
derived: sum of 2 quarters · filed 2021-02-25
$0.00
derived: sum of 3 quarters · filed 2021-02-25
$0.00
10-K · filed 2021-02-25
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$0.00
derived: sum of 2 quarters · filed 2019-11-07
$0.00
10-Q · filed 2019-11-07
$0.00
derived: sum of 4 quarters · filed 2020-02-27
2018-07-01$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$0.00
10-Q · filed 2018-08-09
$0.00
derived: sum of 3 quarters · filed 2020-02-27
$0.00
derived: sum of 4 quarters · filed 2020-02-27
2018-04-01$0.00
10-Q · filed 2018-05-10
$0.00
derived: sum of 2 quarters · filed 2020-02-27
$0.00
derived: sum of 3 quarters · filed 2020-02-27
$415.00M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$0.00
derived: sum of 2 quarters · filed 2020-02-27
$415.00M
derived: sum of 3 quarters · filed 2020-02-27
$1.00B
10-K · filed 2020-02-27
2017-10-01$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$415.00M
derived: sum of 2 quarters · filed 2018-11-08
$1.00B
10-Q · filed 2018-11-08
$1.69B
derived: sum of 4 quarters · filed 2019-02-28
2017-07-02$415.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$1.00B
10-Q · filed 2018-08-09
$1.69B
derived: sum of 3 quarters · filed 2019-02-28
$14.75B
derived: sum of 4 quarters · filed 2019-02-28
2017-04-02$585.00M
10-Q · filed 2018-05-10
$1.27B
derived: sum of 2 quarters · filed 2019-02-28
$14.34B
derived: sum of 3 quarters · filed 2019-02-28
$18.84B
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$689.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$13.75B
derived: sum of 2 quarters · filed 2019-02-28
$18.26B
derived: sum of 3 quarters · filed 2019-02-28
$18.37B
10-K · filed 2019-02-28
2016-10-02$13.06B
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$17.57B
derived: sum of 2 quarters · filed 2017-11-09
$17.68B
10-Q · filed 2017-11-09
$17.82B
derived: sum of 4 quarters · filed 2018-02-22
2016-07-03$4.51B
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$4.62B
10-Q · filed 2017-08-10
$4.76B
derived: sum of 3 quarters · filed 2018-02-22
$20.40B
derived: sum of 4 quarters · filed 2018-02-22
2016-04-03$110.00M
10-Q · filed 2017-05-11
$254.00M
derived: sum of 2 quarters · filed 2018-02-22
$15.90B
derived: sum of 3 quarters · filed 2018-02-22
$15.90B
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$144.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$15.79B
derived: sum of 2 quarters · filed 2018-02-22
$15.79B
derived: sum of 3 quarters · filed 2018-02-22
$16.47B
10-K · filed 2018-02-22
2015-09-27$15.64B
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$15.64B
derived: sum of 2 quarters · filed 2016-11-10
$16.32B
10-Q · filed 2016-11-10
$16.32B
derived: sum of 4 quarters · filed 2017-02-23
2015-06-28$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$679.00M
10-Q · filed 2016-08-11
$679.00M
derived: sum of 3 quarters · filed 2017-02-23
$874.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-29$678.00M
10-Q · filed 2016-05-12
$678.00M
derived: sum of 2 quarters · filed 2017-02-23
$873.00M
derived: sum of 3 quarters · filed 2017-02-23
$873.00M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$195.00M
derived: sum of 2 quarters · filed 2017-02-23
$195.00M
derived: sum of 3 quarters · filed 2017-02-23
$195.00M
10-K · filed 2017-02-23
2014-09-28$195.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$195.00M
derived: sum of 2 quarters · filed 2015-11-05
$195.00M
10-Q · filed 2015-11-05
$195.00M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-29$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$0.00
10-Q · filed 2015-08-06
$0.00
derived: sum of 3 quarters · filed 2016-02-29
$0.00
derived: sum of 4 quarters · filed 2016-02-29
2014-03-30$0.00
10-Q · filed 2015-05-07
$0.00
derived: sum of 2 quarters · filed 2016-02-29
$0.00
derived: sum of 3 quarters · filed 2016-02-29
$15.00M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$0.00
derived: sum of 2 quarters · filed 2016-02-29
$15.00M
derived: sum of 3 quarters · filed 2016-02-29
$15.00M
10-K · filed 2016-02-29
2013-09-29$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$15.00M
derived: sum of 2 quarters · filed 2014-11-06
$15.00M
10-Q · filed 2014-11-06
$283.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$15.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$15.00M
10-Q · filed 2014-08-07
$283.00M
derived: sum of 3 quarters · filed 2015-02-27
$283.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$0.00
10-Q · filed 2013-05-10
$268.00M
derived: sum of 2 quarters · filed 2015-02-27
$268.00M
derived: sum of 3 quarters · filed 2015-02-27
$268.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$268.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$268.00M
derived: sum of 2 quarters · filed 2015-02-27
$268.00M
derived: sum of 3 quarters · filed 2015-02-27
$1.05B
10-K · filed 2015-02-27
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$0.00
derived: sum of 2 quarters · filed 2013-11-08
$782.00M
10-Q · filed 2013-11-08
$876.00M
derived: sum of 4 quarters · filed 2014-02-28
2012-07-01$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$782.00M
10-Q · filed 2013-08-09
$876.00M
derived: sum of 3 quarters · filed 2014-02-28
$895.00M
derived: sum of 4 quarters · filed 2014-02-28
2012-04-01$782.00M
10-Q · filed 2013-05-10
$876.00M
derived: sum of 2 quarters · filed 2014-02-28
$895.00M
derived: sum of 3 quarters · filed 2014-02-28
$895.00M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$94.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$113.00M
derived: sum of 2 quarters · filed 2014-02-28
$113.00M
derived: sum of 3 quarters · filed 2014-02-28
$3.28B
10-K · filed 2014-02-28
2011-10-02$19.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$19.00M
derived: sum of 2 quarters · filed 2012-11-09
$3.19B
10-Q · filed 2012-11-09
2011-07-03$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$3.17B
10-Q · filed 2012-08-09
2011-04-03$3.17B
10-Q · filed 2012-05-10
2010-12-31$273.00M
10-K · filed 2013-02-28
2009-12-31$43.12B
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$43.12B
derived: sum of 2 quarters · filed 2012-02-28
$43.12B
10-K · filed 2012-02-28
2009-09-27$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05
$0.00
10-Q · filed 2009-11-05
2009-06-28$0.00
10-Q · filed 2009-08-06
2008-12-31$222.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28
$222.00M
derived: sum of 2 quarters · filed 2011-02-28
$1.18B
10-K · filed 2011-02-28
2008-09-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05
$962.00M
10-Q · filed 2009-11-05
2008-06-29$962.00M
10-Q · filed 2009-08-06
2007-12-31$464.00M
10-K · filed 2010-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64